CSIMarket
 


Dentsply Sirona Inc   (XRAY)
Other Ticker:  
 

Cumulative Dentsply Sirona Inc 's Total Debt to Equity for Trailing Twelve Months Period

XRAY's Total Debt to Equity for Trailing Twelve Months Period and Total Debt, Equity growth


Select the Comparisons : Select the Ratio:

XRAY Total Debt to Equity for Trailing Twelve Months Period

(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Equity Growth -6.72 % -23.48 % -25.21 % -23.71 % -28.62 %
Y / Y Total Debt Growth 0.35 % 3.7 % -2.75 % -7.21 % -4.48 %
Total Debt to Equity for Trailing Twelve Months Period 0.56 0.55 0.51 0.48 0.45
Total Ranking # 1660 # 1726 # 1690 # 1892 # 1774
Seq. Equity Growth -8.94 % 1.76 % -4.56 % 5.48 % -25.3 %
Seq. Total Debt Growth -5.33 % -2.59 % 11.01 % -1.97 % -2.17 %


Total Debt to Equity for Trailing Twelve Months Period Comment for 12 Months ending at Sep 30 2023
On the trailing twelve months basis Despite repayements of liabilities of -5.33% in III. Quarter, Total Debt to Equity for Trailing Twelve Months Period improved to 0.56, above Dentsply Sirona Inc 's average Total Debt to Equity for Trailing Twelve Months Period.
Total Debt to Equity for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies in Medical Equipment & Supplies industry 88 other companies have achieved lower Total Debt to Equity for Trailing Twelve Months Period than Dentsply Sirona Inc . While total ranking remained unchanged compare to previous quarter at no. .

What is Debt to Equity Ratio?
XRAY Charts and Quotes
Total Debt to Equity XRAY in the most recent quarter
Total Debt to Equity for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 89
Sector # 297
S&P 500 # 1695


Total Debt to Equity for Trailing Twelve Months Period Statistics
High Average Low
0.92 0.4 0
(June 30. 2012)   (Mar 31 2017)




Companies with similar average Total Debt to Equity for Trailing Twelve Months Period for 12 months ending Sep 30 2023, within Medical Equipment & Supplies Industry Total Debt to Equity for Trailing Twelve Months Period
3m Company  1.53 
Tela Bio Inc   1.48 
Apollo Endosurgery inc   1.43 
Bioventus Inc   1.38 
Conmed Corporation  1.36 
Novocure Limited  1.34 
Cerus Corporation  1.21 
Dexcom Inc   1.17 
Artivion Inc   1.13 
Nuvasive Inc  0.99 
Haemonetics Corporation  0.95 
Viewray Inc   0.89 
Plus Therapeutics Inc   0.87 
Carlisle Companies Incorporated  0.86 
Cadre Holdings Inc   0.85 
Integra Lifesciences Holdings Corp  0.82 
Medinotec Inc   0.82 
Icu Medical Inc  0.79 
Msa Safety Incorporated  0.79 
Stryker Corp  0.77 
Eargo Inc   0.74 
Zimvie Inc   0.73 
Neuronetics inc   0.71 
Tandem Diabetes Care Inc   0.71 
Masimo Corp  0.71 
Infusystem Holdings Inc  0.69 
Integer Holdings Corporation  0.67 
Acutus Medical Inc   0.66 
Pear Therapeutics Inc   0.66 
National Vision Holdings Inc   0.64 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com